Related Experiment Video
Updated: Dec 24, 2025
10:30
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
5.6K
Botulinum Neurotoxins: Mechanism of Action
O Rossetto1, M Pirazzini1, F Fabris1
1Department of Biomedical Sciences, University of Padova, Padova, Italy.
Handbook of Experimental Pharmacology
|April 12, 2020
Summary
Botulinum neurotoxins (BoNTs) are potent bacterial toxins causing botulism. Their unique molecular mechanism enables targeted nerve paralysis, explaining their extreme toxicity and pharmaceutical value.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- Botulinum neurotoxins (BoNTs) are potent bacterial protein toxins responsible for botulism.
- Their extreme potency stems from a unique molecular architecture and mechanism of action.
- BoNTs target peripheral nerve terminals, inhibiting neurotransmitter release.
Purpose of the Study:
- To review the molecular mechanism of BoNTs in causing nerve paralysis.
- To highlight key aspects explaining BoNTs' toxicity and pharmacological properties.
Main Methods:
- Review of scientific literature on Botulinum neurotoxins.
- Analysis of the molecular steps involved in BoNTs' mechanism of action.
Main Results:
- BoNTs bind specifically to peripheral nerve terminals and enter the cytosol.
- They cleave SNARE proteins, inhibiting neurotransmitter release and causing paralysis.
- Reversible action and specific binding limit neuroparalytic effects.
Conclusions:
- Understanding BoNTs' molecular mechanism is crucial for explaining their toxicity.
- BoNTs' properties make them valuable pharmaceuticals for treating hypercholinergic conditions.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.0K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.0K
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.6K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.6K
01:29Neuromuscular Junction And Blockade
4.4K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
4.4K
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
801
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
801
01:28Depolarizing Blockers: Mechanism of Action
2.5K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.5K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.4K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.4K